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Abstract
Autophagy is a mechanism of intracellular degradation within eukaryotes. Because of its aid to a cells
longevity, autophagy is believed to be important for the prevention of neurodegenerative diseases. Autophagy
related protein 11 (Atg11) is a coiled-coil scaffolding protein required for selective autophagy in yeast. Atg11
is known to interact with Atg1, Atg20, and Atg29, in addition to connecting cargo molecules prApel -Atg19 to
the phagophore assembly site. In addition to its many functions within yeast autophagy, Atg11 has two human
homologs: Huntingtin protein and FIP200. This homology encourages us to gain a further understanding of
Atg11's binding sites. In this study we show that making two mutations within the coiled-coil domain 2 of
Atg11, 1562E/Y565E, causes it to lose its ability to interact with Atg1.
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Determining Atgll's Binding Interactions Using a Yeast 
Two Hybrid System and Directed 
Abstract: 
Autophagy is a mechanism of intracellular degradation within eukaryotes. Because of its aid to a 
cells longevity, autophagy is believed to be important for the prevention of neurodegenerative diseases. 
Autophagy related protein 11 (Atgl I) is a coiled-coil scaffolding protein required for selective autophagy 
in yeast. Atgl I is known to interact with Atgl, Atg20, and Atg29, in addition to connecting cargo 
molecules prApel -Atg19 to the phagophore assembly site. In addition to its many functions within yeast 
autophagy, Atgl 1 has two human homologs: Huntingtin protein and FIP200. This homology encourages 
us to gain a further understanding of Atgl l's binding sites. In this study we show that making two 
mutations within the coiled-coil domain 2 of Atgl I, 1562E/Y565E, causes it to lose its ability to interact 
with Atgl. 
Introduction: 
For all eukaryotic cells, degradation of intracellular material is required for survival. Whether it 
be degradation of nonspecific material for nourishment, foreign pathogens, damaged organelles, or 
various protein aggregates, the ability to degrade and eventually recycle intracellular material is important 
for a cell to maintain homeostasis. Autophagy is a process conserved throughout eukaryotes that carries 
out intracellular degradation by wrapping intracellular content into a double membrane bilayer, referred to 
as an autophagosome, and transporting it to a lysosome (or vacuole in yeast) for degradation (1). 
Autophagy has many potential therapeutic applications (2). Most notably, autophagy is believed to aid in 
the prevention of many neurodegenerative diseases by aiding in intracellular upkeep by degrading protein 
aggregates in neurons. (3) 
The process of autophagosome formation (Figure 1) begins with the emergence of a membrane 
that sequesters intracellular material to be degraded (4). This new vesicle, referred to as a phagophore, 
continues to expand and elongate. The phagophore eventually matures into a double membrane 
autophagosome upon complete expansion and loss of its core protein constituents. The mature 
autophagosome then completes its journey to degradation by fusing with a lysosome or vacuole, 
depending on the eukaryote. 
Autophagosome 
e 
Figure I General maturation of an autophagosome: This figure shows the fonnation of an 
autophagosome starting with the phagophore assembly site (a), fonnation of a phagophore (b), 
autophagosome ( c ), and then eventual fusion with a lysosome to fonn an autolysosome ( d). (Figure 
adapted from 4) 
Autophagy is further classified based off of the material to be degraded. The two primary 
classifications of autophagy are non-selective (bulk) and selective autophagy (5). Of the two fonns, bulk 
autophagy is more understood within the scientific community. In brief, bulk autophagy is non-specific 
degradation of intracellular material in response to starvation conditions. Selective autophagy on the other 
hand is less understood, and arguably more important within cells such as neurons and myofibrils that 
exist over the course of one's lifetime and require more upkeep to maintain normal protein and organelle 
function. 
In contrast to bulk autophagy, which is stimulated by starvation conditions, selective autophagy is 
induced by many different stimuli that induce autophagy. Stimuli including foreign proteins degraded by 
xenophagy, denatured protein aggregates being degraded by aggrephagy, damaged mitochondria being 
degraded by mitophagy, and intracellular lipid droplets by lipophagy, selective autophagy seems to have a 
response for any stimuli (8). However, selective autophagy does have its limitations, and it is thought that 
many diseases may be traced back to limitations of selective autophagy. 
An example of selective autophagy's role in various diseases may be found in neurons. 
Mitochondrial activity within neurons is high due to the energy demand, and because of this dysfunction 
many free radicals are formed (6). Many of these free radicals are believed to be responsible for the 
protein aggregates which are commonly associated with diseases such as alzheimer's and dementia (7). 
Mitophagy and aggrephagy immediately come to mind to combat these stresses (8). In addition, it has 
been found within cells showing neurological dysfunction, autophagic activity is hindered at its core 
machinery (9). For these reasons, the underlying mechanisms behind selective autophagy's core 
machinery must be understood. 
The most common model organism for autophagy is Saccharomyces cerevisiae (hereafter 
referred to as yeast) which contain over 35 autophagy related proteins (Atg) that carry out autophagy (10). 
Atgl I has drawn the attention of many due to one of its human homologs, Huntingtin protein (4). When 
Huntington's protein misfolds it is toxic to neurons throughout the brain and is associated with 
Huntingtons disease. However, the proteins exact function is unknown. Because of its homology with 
Atgl 1, Huntingtin's protein is believed to play a role in selective autophagy within neurons. In yeast, 
Atgl 1 is a coiled-coil scaffolding protein that is needed at the phagophore assembly site for selective 
autophagy to occur. Atgl I does this by binding to a variety of partners including Atgl, Atg20, and Atg29, 
in addition to connecting cargo molecules prApel -Atg19 to the PAS allowing for the autophagosome to 
be formed (12-14). 
Atgl 1 's binding partners have been found to do many things. Atg20 is involved with pexophagy 
and mitophogy, while Atg29's interactions with Atgl l activate Atgl (14-15). Atgl 's interactions with 
Atgl I are of interest due to the role Atgl has in selective autophagy. Atgl is essential for all fonns of 
autophagy. Atgl complexes with Atg13 and Atgl 7 during non-selective autophagy in addition to 
organizing the phagophore assembly site (PAS) (16). Additionally, Atgl serves as a kinase that affects 
protein localization to the PAS in both fonns of autophagy. In selective autophagy, Atgl 7 is swapped out 
for Atgl I which as previously stated, interacts with Atgl . 
Atgl 1 's CC2-3 (Figure 2) allow for Atgl 1 's self-interaction along with its interactions with Atgl 
(13). Coil-coiled proteins are well understood to contain a heptad repeat that allows for unique properties 
( 17). Heptad repeats, denoted as abcdefg. have a repeating pattern of amino acids that allows for a protein 
to fold in a coil-coiled fashion. In the repeat, aid are known to be nonpolar central residues, b/c/f are non­
specific, and e/g are hydrophilic or charged residues. This pattern allows for a protein to fold into a coil­
coiled protein, but also for one to make speculations regarding a proteins structure without 
crystallography. Using sequence homology one may predict whether or not a protein has coil-coiled like 
characteristics based off of the heptad repeat. This is exactly how Atgl 1 was first characterized (18). 
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Figure 2Atgll's Coiled-coil domains: Atgl l's CC2-3 interact with Atgl,20,29, along with itself in 
nonselective autophagy (Figure courtesy Dr. Steven Backues). 
Currently, there is no crystal structure available for Atgl I, so it's three dimensional structure is 
not known, and the specific residues and nature of Atgl 1 's binding interactions is not understood. Atgl l 
could interact with its binding partners using a single competitive binding site within this region, or Atgl l 
could have multiple binding sites for multiple interactions to occur at the same time. Previous results have 
found that coiled-coil domain 2 is essential for Atgl I's interaction with Atgl ,  Atg20, Atg29 and itself, 
but the exact residues within these sites necessary for binding have yet to be mapped. The goal of this 
senior thesis is to use a yeast two hybrid screen along with directed mutagenesis to dissect the nature of 
Atgl l 's interactions with its binding partner Atgl .  I hypothesize that I will be able to prevent the 
interaction of Atgl 1 interactions with specific binding partners such as Atgl through direct mutations to 
individual amino acid residues within the CC2. 
Results: 
A yeast two hybrid assay is a molecular biology technique that involves two plasmids with a 
binding domain and an activating domain. The first plasmid, called pGBDU, contains a protein of interest 
fused to a DNA binding domain, and a gene enabling yeast to grow in uracil deficient conditions. The 
second plasmid is a pGAD plasmid that contains a transcription activating domain fused to a protein that 
is believed to be a binding partner of the protein in the pGBDU, and a gene enabling growth in leucine 
deficient conditions. Yeast are first transformed with the plasmid containing the binding domain. If the 
transformation is successful and the yeast grow in uracil deficient conditions, a second transformation is 
done using the plasmid containing the activating domain. If this transformation is successful and the yeast 
are able to grow on uracil and leucine deficient conditions, a screen ensues where the yeast are plated on 
media deficient in uracil, leucine, and adenine. If the cell line grows, it may be concluded that the binding 
domain has attached to the activating domain through the two proteins interactions, and proteins enabling 
for growth in adenine deficient media were transcribed. 
To validate our yeast two hybrid screen, a control experiment was set up within a PJ69-4a strain. 
Using pGBDU plasmids containing full length ATG20, ATG29, and ATGL�K* (Atgl missing a kinase 
domain to prevent autoactivation), a screen was run versus pGAD-ATG 1 1, pGAD-ATG 1 1ACC2, and 
pGAD-empty (Figure 3). It was found that full length pGAD-ATGI I tested positive in the screen while 
pGAD-ATG I ldCC2, and pGAD-empty tested negative for protein interactions with AtglAK and Atg29. 
In contrast, Atg20 showed low levels of growth with pGAD-A TG 1 1  so it was ruled out as a possible 
binding partner of Atgl 1 for our screen. The positive test for protein interactions of full length Atgl 1 with 
AtglAK and Atg29 corresponds with previously published data, thus validating our yeast two hybrid 
system (I 3-15). 
Figure 3 Full length pGBDUATG114K, pGBDUATG20 and pGBDUATG29 versus pGAD-ATGll. 
pGAD-ATGI l4CC2. and pGADempty. Streaking was done on plates lacking in uracil and leucine (non­
selective) and lacking in uracil, leucine, and adenine (selective). It was found that AtglaK interacts with 
full length Atgl 1 (a), while not interacting with Atgl l.6.CC2 (b) and an empty pGAD (c). Atg20 showed 
a mild amount of growth so no conclusions may be made regarding it's interactions with Atgl 1 (d), 
Atgl 1ACC2 (e) and an empty vector (f). Atg29 shows interactions with Atgl 1 (g), and a small amount of 
growth with Atgl 1ACC2 (h) and an empty pGAD (i). 
To test which residue within the 2nd coiled-coil region was most important for Atgl l's 
interactions, mutants were made of Atgl l in the pGAD plasmid containing full length Atgl 1 .  Utilizing 
the heptad repeat, three sets of"full" mutations were made in the CC2: one of all aid nonpolar residues, 
one of all e/g charged residues, and one of all b/c/f non-specific amino acid residues. The aid amino 
acids were all mutated to glutamate, b/c/f amino acids to alanine, and e/g amino acids to alanine. Each of 
these three mutants were then screened against AtglAK (Figure 4). It was found that full length aid 
mutants lost interactions with Atglal(. while full length b/c/f and e/g mutants of the CC2 did not lose 
interaction. The amino acid sequence of the full length aid mutants is shown in Figure S. 
Figure 4 Full length pGBDUATGl�K versus full length aid, blc/1, and e/g mutants. A positive control 
(+) came from colonies containing pGBDUATGIAK and pGADATGl 1 while a negative control(-) 
contained pGBDUATGlAK and pGADempty. AtglAK was found to maintain interaction with full length 
e/g mutants (a and b) and full length b/c/f mutants ( c and d), while it showed a loss of interaction with full 
length aid mutants (e and f). 
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Figure 5 Full length aid mutants within the AtgllCC2 amino acid sequence. Mutations for the full 
length aid mutants are indicated with black boxes. Specific amino acid substitutions may be compared to 
the wild type amino acid sequence denoted by "Wild Type." 
To locate the exact residue required for Atgl l's interactions with Atgldl<., a further screen was 
done using a pGAD plasmid containing Atgl I with the CC2 containing specific mutations of aid amino 
acids to glutamate. Specifically, the three mutants used were 1548E/Y551E, L555E/V558E, and 
1562E/Y565E. It was found that plasmids with mutations 1562E/Y565E lost interaction with Atgldl<. 
(Figure 6), while the other two directed mutants maintained interactions. The amino acid sequence of aid 
mutant 1562E/Y565E is shown in Figure 7. 
Figure 6 pGBDUATGJtJK versus specific aid mutants. A positive control{+) came from colonies 
containing pGBDUA TG 1 Af<. and pGADA TG 11 while a negative control (-) contained pGBDUA TG l Af<. 
and pGAOempty. AtglAf<. was found to interact with some Atgl 1 plasmids containing 1548/YSSI 
mutated to glutamate (a) while losing interaction with others (b). Interaction maintained in mutants 
containing L555NS58 mutated to glutamate (c and d). but lost in mutants ofl562/Y565 to glutamate (e 
and f). 
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Figure 7 aid mutant 1562EIY565E within Atgllcc2. Mutations l562E/Y565E are shown compared in the 
"aid mutant" to the "Wild Type" Atgl 1CC2. 
Discussion: 
In this paper, we show that the second coiled-coil region within Atgl 1 is necessary for its 
interactions with Atgl and Atg29. We also show that Atgl�K loses interaction with Atgl 1 with 
mutations to amino acids l562E/Y565E. We hypothesize that our mutation affects the specific binding 
site. However, our mutations to amino acids l562E/Y565E may have caused Atgl 1 to improperly fold. To 
make sure the protein has maintained its three dimensional structure two tests will be done. The first will 
be to test whether or not our mutant maintains interaction with Atg32, an interaction that occurs in the 
CC4 and does not depend on the CC2, using our yeast two hybrid system. If this interaction also is lost 
within our mutant it may be concluded that mutations at the l562E/Y565E residue cause systemic 
misfolding of the protein that prevents any conclusions from being drawn regarding its specific binding 
sites. However, if this mutant of Atgl 1 does not cause systemic disorder within the protein as shown by 
our mutant maintaining Atgl 1 's protein interactions outside of the CC2 in our yeast two hybrid system, 
we will do a Western Blot to test for expression levels. When a protein misfolds it often is expressed at 
low levels. A Western Blot of our mutant will be done comparing it to the wild type Atgl 1 protein. If the 
expression levels are the same, it is believed that the mutant is being expressed at normal levels and 
therefore is folding properly. While on the other hand, if the mutant has lower expression levels, we will 
conclude that the mutant has misfolded. 
If our hypothesis is correct and the mutant Atg 11 maintains its structure, but loses interactions 
with its other previously reported binding partners Atg9, 20 and 29, this would suggest that there is one 
competitive binding site that is responsible for all of Atg 11 's protein interactions ( 12-14 ). However, if the 
mutant Atg 11 maintains its binding ability to bind with other binding partners, this data supports multiple 
binding sites within the protein, with Atgl binding at a location distinct from that of the other partners. If 
this were the case, additional yeast two hybrid tests with Atgl l's binding partners would be done using 
other directed mutants of Atgl 1. 
Materials and Methods: 
Transformation Protocol: 
Yeast strains were grown to an OD600 of approximately 1.0 in 5 mL of the appropriate 
media outlined in Table 1. Cultures were spun down at 2000 g for 5 minutes, resuspended in 5 
mL of water, and spun down again. Yeast were then transferred to a 1.5 mL centrifuge tube with 
1 mL of water and spun down at max speed. The supernatant was removed and yeast were 
resuspended in solution containing 240 µL 50% v/v PEG 3350, 36 µL lM Li Ac, 10 µL 
1 0mg/mL single stranded carrier DNA (boiled and cooled}, 1 µL plasmid DNA, 73 µL H20. 
Tubes were incubated for 30 minutes at 420. Following the incubation, tubes were then spun 
down at 4000 g for 3 minutes and the supernatant was removed. Yeast were then resuspended in 
1 mL of the original media (Table 1) and incubated for 1 hour at 300 with rotation. Following 
incubation the yeast were spun down again at 4000 g for 3 minutes and resuspend tubes in 1 mL 
of water. 100µ1 of the resuspension was then plated on appropriate media to select for the 
plasmid being transformed (10% plate}. The solution was spun down again and all was plated 
(90% plates). Plates were incubated at 300 and incubate for 4 days. 
Table I: Media used for different plasmids 
Plasmid Type Media Media Components (w/v) 
None -wild type yeast strain YPD I% yeast extract, 2% peptone, 2% agar, 
2%glucose 
pGBDU SMD-uracil 0.69% yeast nitrogen base, 0.5% 
casamino acids, 2% agar, 2% glucose, 
2.5% (v/v) AA2, 5% (v/v) AA -ura 
pGAD SMD - uracil - leucine 0.69% yeast nitrogen base, 2% agar, 2% 
glucose, 10% (v/v) AAI, 2.5% (v/v) 
AA2, S% (v/v) AA -ura, leu 
pGBDU and pGAD interaction SMD -uracil - leucine - adenine 0.69% yeast nitrogen base, 2% agar, 2% 
glucose, (v/v) AAI, 2.5% (v/v) AA2, 
5% (v/v) AA - ura, leu, ade 
Table 2: Amino Acid Components in Media 
AAl Alanine 300 ppm, arginine 200 ppm, espartate 1000 ppm, 
glutamate I 000 ppm, glycine 200 ppm, isoleucine 300 ppm, 
methionine 200 ppm, phenylalanine 410 ppm, proline 300 
ppm, serine 4000 ppm, threonine 4000 ppm, tyrosine 300 
ppm, valine 1500 ppm 
AA2 Asparagine 1600 ppm, glycine 1600 ppm, cysteine 1600 ppm 
AA - ura 300 ppm adenine, 200 ppm histidine, 500 ppm leucine, 300 
ppm lysine, 500 ppm tryptophan 
AA - ura, Jcu 300 ppm adenine, 200 ppm histidine, 300 ppm lysine, 500 
ppm tryptophan 
AA - ura, leu, ade 200 ppm histidine, 300 ppm lysine, 500 ppm tryptophan 
Yeast-Two Hybrid Screen: 
The screen began with transforming a strain containing a pGBDU plasmid with the 
appropriate pGAD plasmid and plating the products of this transformation on media lacking in 
uracil and leucine. This allowed all yeast containing these two plasmids to grow, regardless of an 
interaction. Two colonies were selected from this plate and struck on two new plates. The first 
plate the colonies were struck on was one lacking in uracil, leucine, and adenine, (the selective 
plate). The second plate was lacking only uracil and leucine (non-selective plate). These plates 
were then grown for 3 days in a 30 D incubator. Loss of interaction was concluded if a colony 
that grew on plates lacking in uracil and leucine could not grow on plates lacking in uracil, 
leucine, and adenine. Images were acquired using BioRad ChemiDoc XRS+ Molecular lmager 
and the manufacturer's protocol. 
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